Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-085270
Filing Date
2021-06-24
Accepted
2021-06-24 18:22:32
Documents
2
Period of Report
2021-06-24

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2120455d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2120455d1_3.xml 3 8421
2 EXHIBIT 24 tm2120455d1_ex24.htm EX-24 8060
  Complete submission text file 0001104659-21-085270.txt   18070
Mailing Address 40 WASHINGTON STREET SUITE 220 WELLESLEY HILLS MA 02481
Business Address
DELUCCIA ROBERT J (Reporting) CIK: 0001127423 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-40536 | Film No.: 211044068
SIC: 2834 Pharmaceutical Preparations

Mailing Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305
Business Address 259 LIBERTY AVENUE STATEN ISLAND NY 10305 917-533-1469
Acurx Pharmaceuticals, Inc. (Issuer) CIK: 0001736243 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations